Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7793281 | 1.00 | POLB (0.42) | POLBTAS1R3TAS1R1TAS1R2RAB9A | |
| SCHEMBL171236 | 0.91 | POLB (0.47) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL7794525 | 0.83 | RAB9A (0.51) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL2478210 | 0.83 | RAB9A (0.56) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL12162974 | 0.82 | RAB9A (0.44) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL21920151 | 0.82 | POLB (0.44) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL12908034 | 0.82 | RAB9A (0.44) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL7130956 | 0.82 | CA12 (0.42) | POLBRAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL13450023 | 0.82 | SMN1; SMN2 (0.46) | POLBRAB9ANPC1SMN1; SMN2CYP3A4 | |
| SCHEMBL13450330 | 0.82 | POLB (0.62) | POLBRAB9ANPC1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10766851-B1 | Method to convert lignin 4-O-5 diaryl ethers and their model compounds into organic chemicals | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY (CA) | 2020-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10766851-B1 | Method to convert lignin 4-O-5 diaryl ethers and their model compounds into organic chemicals | PPOX, DAO, PAH | POLB 559/4885TAS1R3 3796/4885TAS1R1 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.